Significance of necrosis in grading of oligodendroglial neoplasms: A clinicopathologic and genetic study of newly diagnosed high-grade gliomas

Journal of Clinical Oncology

Volumn 24, Issue 34, 2006, Pages 5419-5426

  Miller, C Ryan ^a   Dunham, Christopher P ^a   Scheithauer, Bernd W ^a   Perry, Arie ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; CELL DEATH; CELL PROLIFERATION; CHROMOSOME 10Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 7P; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOGENETICS; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECROSIS; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS; BRAIN TUMOR; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICAL MODEL; SURVIVAL;

ADULT; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NECROSIS; OLIGODENDROGLIOMA; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33847677719     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.1497     Document Type: Article

References (23)

1. Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Hinsdale, IL, Central Brain Tumor Registry of the United States, 2006
2. Kleihues P, Cavenee WK: International Agency for Research on Cancer: Pathology and Genetics of Tumours of the Nervous System. Lyon, France, International Agency for Research on Cancer Press, 2000
3. Aldape K, Simmons ML, Davis RL, et al: Discrepancies in diagnoses of neuroepithelial neoplasms: The San Francisco Bay Area Adult Glioma Study. Cancer 88:2342-2349, 2000
4. Coons SW, Johnson PC, Scheithauer BW, et al: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381-1393, 1997
5. Prayson RA, Agamanolis DP, Cohen ML, et al: Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 175:33-39, 2000
6. Bailey P, Cushing H: A Classification of the Tumors of the Glioma Group on a Histogenetic Basis With a Correlated Study of Prognosis. Philadelphia, PA, J.B. Lippincott Company, 1926
7. Burger PC: What is an oligodendroglioma? Brain Pathol 12:257-259, 2002
8. Perry A: Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore. Adv Anat Pathol 8:183-199, 2001
9. Reifenberger G, Louis DN: Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62:111-126, 2003
10. Brat DJ, Castellano-Sanchez A, Kaur B, et al: Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv Anat Pathol 9:24-36, 2002
11. Bauman GS, Ino Y, Ueki K, et al: Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 48:825-830, 2000
12. Cairncross JG, Ueki K, Zlatescu MC, et al: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479, 1998
13. Perry A, Fuller CE, Banerjee R, et al: Ancillary FISH analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 8:a1-a9, 2003
14. Smith JS, Perry A, Borell TJ, et al: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645, 2000
15. Burger PC, Pearl DK, Aldape K, et al: Small cell architecture: A histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol 60:1099-1104, 2001
16. Perry A, Aldape KD, George DH, et al: Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer 101:2318-2326, 2004
17. Fuller CE, Schmidt RE, Roth KA, et al: Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J Neuropathol Exp Neurol 62:1118-1128, 2003
18. Fallon KB, Palmer CA, Roth KA, et al: Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63:314-322, 2004
19. Giannini C, Scheithauer BW, Weaver AL, et al: Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60:248-262, 2001
20. Brat DJ, Seiferheld WF, Perry A, et al: Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. Neurooncol 6:96-103, 2004
21. van den Bent MJ, Carpentier AF, Brandes AA, et al: Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715-2722, 2006
22. Smith SF, Simpson JM, Brewer JA, et al: The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: Review of 98 patients. J Neurooncol 80:75-82, 2006
23. Cairncross G, Berkey B, Shaw E, et al: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24:2707-2714, 2006